
High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients
Author(s) -
Claire Bossard,
Birgit Schramm,
Stephen Wanjala,
Lakshmi Jain,
Gisele Mucinya,
Valarie Opollo,
Lubbe Wiesner,
Gilles Van Cutsem,
Elisabeth Poulet,
Elisabeth Szumilin,
Tom Ellman,
David Maman
Publication year - 2021
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002689
Subject(s) - medicine , zidovudine , viral load , drug resistance , hiv drug resistance , reverse transcriptase inhibitor , lamivudine , efavirenz , viremia , virology , antiretroviral therapy , human immunodeficiency virus (hiv) , viral disease , virus , hepatitis b virus , biology , microbiology and biotechnology
Patients hospitalized with advanced HIV have a high mortality risk. We assessed viremia and drug resistance among differentiated care services and explored whether expediting the switching of failing treatments may be justified.